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Identification of Stage-Specific Antigens of Toxoplasma gondii
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An immunologic evaluation of the surface antigens of the three major life-cycle stages of Toxoplasma gondii
was performed. Mouse antisera were raised against these stages, which included the oocyst-sporozoite
(feline-excreted stage), bradyzoite (chronic tissue cyst stage), and tachyzoite (invasive stage). The antisera were
used in an enzyme-linked immunosorbent assay and Western blot (immunoblot) analysis to demonstrate the
presence of stage-specific antigens. These antigens were of various molecular weights and were specific to each
stage investigated. Cross-reaction studies showed that the mouse antisera recognized commonly shared
antigens to at least two of the three stages. A panel of monoclonal antibodies identified specific immune epitopes
unique to each of the stages investigated. These studies further support the hypothesis that stage-specific
antigens are present in T. gondii.
Although the morphologic characteristics of the life-cycle
stages of Toxoplasma gondii have been well documented, a
detailed immunologic analysis has not been reported (1, 2, 9,
11). We have previously described the identification of
stage-specific oocyst-sporozoite antigens of T. gondii by
monoclonal antibodies (3). These monoclonal antibodies
identified at least two unique oocyst-sporozoite antigens that
were not expressed on the surface of the tachyzoite. Recog-
nition of stage-specific oocyst-sporozoite antigens also has
been demonstrated by using human sera from an epidemio-
logically well-documented outbreak of oocyst-transmitted
infection (6).
In immunofluorescence studies, bradyzoites (cystozoites)
have also been found to exhibit stage specificity (8). Simi-
larly, we have shown that some monoclonal antibodies
directed at tachyzoite antigens are nonreactive toward
bradyzoites (5). Thus, it appears that there are unique
antigens that may immunologically characterize the three
major morphologic life-cycle stages of toxoplasma. We
report here the presence of such stage-specific T. gondii
antigens.
MATERIALS AND METHODS
Parasites. P-strain parasites were obtained from the Me49
line of T. gondii (kindly supplied by M. Lunde, National
Institutes of Health) and cloned in our laboratory. This strain
produces high numbers of brain tissue cysts in mice and was
used for both bradyzoite and tachyzoite preparations.
Bradyzoites were produced by infecting mice intraperitone-
ally with purified P-strain-infected brain cysts and allowing 8
weeks for brain cysts to develop. To purify brain cysts, mice
were exsanguinated, and their brains were removed and
rinsed in phosphate-buffered saline (PBS). Each brain was
homogenized in 2 ml ofPBS, and the homogenate was mixed
with an equal volume of 30% dextran (Mr, 229,000). This
mixture was centrifuged at 1,400 x g for 20 min. The pellet
was washed once and resuspended in PBS. To prepare
bradyzoite lysates, brain cysts were freeze-thawed five times
in a dry ice-methanol bath. The suspension was then soni-
cated eight times (18,000 Hz) at 10-s intervals at 4°C,
solubilized by adding Nonidet P-40 to 0.5%, and stored at
-200C.
P-strain tachyzoites were produced by infecting human
fibroblast monolayers with P-strain-infected mouse brain
tissue that had been homogenized and forcibly passed
through a 27-gauge needle. These were maintained as tachy-
zoites by continuous passage in human fibroblast cells.
Oocysts were obtained in a manner similar to that previ-
ously described (9, 10). Briefly, infected mice were sacri-
ficed, and an estimated 1,000 brain cysts were fed to nonim-
mune kittens. Feces were collected daily and purified by
flotation in a sucrose gradient. The oocysts were allowed to
sporulate at room temperature for several days in 0.5 N
sulfuric acid and stored at 4°C. To prepare oocyst-sporozoite
lysates, oocysts were washed several times in Hanks bal-
anced salt solution and freeze-thawed five times in a dry
ice-methanol bath. The suspension was then sonicated eight
times (18,000 Hz) at 10-s intervals at 4°C, solubilized by
adding Nonidet P-40 to 0.5%, and stored at -20°C.
Autoradiogram. Surface antigens of each life-cycle stage
were iodinated by the lodogen method as previously de-
scribed (14). Bradyzoites were released from purified brain
cysts by incubating the cysts with 0.01 M pepsin in 0.01 N
HCl for 1 min and syringing the bradyzoites through a
27-gauge needle. Sporozoites were released from oocysts by
mechanical fracture. Tachyzoites were released from host
cells by forced extrusion through a 27-gauge needle. lodin-
ated samples were run on a 12.5% polyacrylamide gel,
stained, dried, and autoradiogramed for 2 weeks with a
I Cronex Lightning-Plus intensifying screen.
I Preparation of mouse antitoxoplasma antisera. BALB/c
mice (Jackson Laboratory) were immunized in three doses
with sonicated and freeze-thawed parasites of each life-cycle
stage of T. gondii. Freund complete adjuvant was used in the
first dose and Freund incomplete adjuvant was used for the
remaining two doses. Mice were bled 10 days after the final
dose. The pooled sera from at least three mice was used as
the source of antiserum.
ELISA. Antitoxoplasma antibody was measured by an
enzyme-linked immunosorbent assay (ELISA). Purified par-
asites were placed in microdilution plates, dried overnight,
and blocked with 5% fetal bovine serum-PBS. Antisera were
incubated for 2 h at 37°C, and the plates were washed in
0.05% Tween 20-PBS. Antibody binding was identified with
peroxidase-labeled goat anti-mouse immunoglobulin G (IgG)
or IgM (Boehringer Mannheim Biochemicals).
Polyacrylamide gel electrophoresis. Parasite samples were
dissolved in sample buffer that contained 2% sodium dodecyl
sulfate and 5% 2-mercaptoethanol. After being boiled for 3
min, samples were electrophoresed in a 0.1% sodium dode-
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FIG. 1. (A) Autoradiogram of iodinated parasites of the three life-cycle stages of T. gondii. Parasites were purified and iodinated by the
lodogen method, run on a 12.5% polyacrylamide gel, and autortdiogramed with a Cronex Lightning-Plus intensifying screen. This
autoradiogram represents equal numbers of tachyzoites (T), bradyzoites (B), and oocyst-sporozoites (O/S) run in parallel and autoradio-
gramed for 2 weeks. Molecular weight standards (103) are indicated. (B) Analysis of the lanes in panel A with a videodensitometer (model 620;
Bio-Rad Laboratories). Tachyzoites; ------, bradyzoites; ......oocyst-sporozoites. Base-line values have been subtracted for
standardization.
cyl sulfate discontinuous 12.5% polyacrylamide gel. Molec-
ular weight standards included ,-galactosidase (116,000),
phosphorylase b (97,000), bovine albumin (66,000), egg
albumen (45,000), carbonic anhydrase (29,000), trypsinogen
(24,000), ,-lactoglobulin (18,400), and lysozyme (14,300).
Nitrocellulose blot transfer electrophoresis. After sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, gels
were applied to a sheet of nitrocellulose paper (0.2-pLm pore
size) and electrophoresed for 2 h with a Transfor apparatus
(13). After electrophoresis, the remaining protein-binding
sites on the nitrocellulose paper were blocked with 3%
bovine serum albumin in PBS (pH 7.4) overnight at 4°C.
Strips were then incubated with appropriate antisera diluted
1:200 in 3% bovine serum albumin-PBS for 2 h at room
temperature. The nitrocellulose was washed several times in
0.05% Tween 20-PBS and incubated with peroxidase-la-
beled goat anti-mouse IgG or IgM (diluted 1:5,000). The
strips were washed and developed in a solution of 0.02%
4-chloro-1-naphthol-0.1% hydrogen peroxide in PBS.
Monoclonal antibodies. Production of bradyzoite-specific
monoclonal antibodies was accomplished by using our pre-
viously reported murine hybridoma method (3, 4). Briefly,
mice were immunized over a 3-week period with a total of
1.5 x 107 bradyzoite parasites. Immunization was performed
weekly, with injection 1 made in the presence of Freund
complete adjuvant and injections 2 and 3 with Freund
incomplete adjuvant. Immunized mice were sacrificed 1
week after the final immunization booster, the spleen was
removed, and spleen cells were fused with NS-1 myeloma
cells in a standard fusion protocol. Culture supernatant from
confluent wells was tested for antibradyzoite antibody by
ELISA. Positive wells were cloned by limiting dilution,
expanded in culture, and used to produce ascites in pristane-
pretreated mice.
RESULTS
Radioiodination was performed to determine whether T.
gondii exhibits stage-specific surface membrane proteins.
Both bradyzoites and oocyst-sporozoites were released from
their cyst walls and radioiodinated by the lodogen tech-
nique. Tachyzoites were obtained from tissue culture and
radiolabeled. Equal numbers of parasites were run in parallel
on 12.5% sodium dodecyl sulfate-polyacrylamide gel and
autoradiogramed. There were radioiodinatable proteins of
different and common molecular weights in each life-cycle
stage (Fig. 1A). Both stage-specific and shared iodinated
parasite proteins could be seen at different molecular
weights. Analysis by videodensitometry showed the relation
among these radioiodinated parasite proteins from the three
stages (Fig. 1B). Similar results were obtained when equal
numbers of radioactive counts for each stage were compared
by gel electrophoresis and autoradiography (not shown).
To better determine stage specificity, mouse antitoxo-
plasma sera were examined by ELISA for the presence of
antibodies to bradyzoites, tachyzoites, and oocyst-sporozo-
ites. We have shown previously that tachyzoites and sporo-
zoites bind with equal affinity to a solid substrate (6). To
demonstrate that the bradyzoites also adhere, equal numbers
(5 x 105) of bradyzoites, tachyzoites, and sporozoites were
purified, radioiodinated by the lodogen method, and depos-
ited in microdilution plates. The plates were blocked in 5%
fetal bovine serum, washed, and counted. Similar results
were obtained when an equal number of counts (50,000 cpm
per well) was used. By this method, it was determined that
bradyzoites bind to microdilution plates as well as tachyzo-
ites and sporozoites do.
The results of the ELISA for antibody stage specificity are

















TABLE 1. ELISA titers of pooled immune mouse antisera to





Bradyzoites 450 1,350 12,150
Oocyst-sporozoites 36,450 450 1,350
Tachyzoites 450 12,150 1,350
IgM
Bradyzoites 1,350 450 1,350
Oocyst-sporozoites 1,350 150 150
Tachyzoites 1,350 450 450
a Parasites were used at a concentration of 104 per well.
their corresponding stages had the highest antibody titers.
For example, anti-oocyst-sporozoite serum had an antibody
titer of 36,450 against oocyst-sporozoites. This was several-
fold greater than its reactivity against tachyzoites or brady-
zoites. Conversely, the titers of antibradyzoite and anti-
tachyzoite sera against oocyst-sporozoites were both 450. A
similar degree of stage specificity was demonstrated by the
other mouse antisera. The antitachyzoite antibody titer was
greatest against tachyzoites. Similarly, the antibradyzoite
sera demonstrated the highest specificity against bradyzo-
ites. Both of these sera failed to distinguish between the
noncorresponding stages. These differences in titer are prob-
ably not due to strain variation. We have previously shown
that the ELISA is of insufficient sensitivity to distinguish
among strains when strain-specific rabbit antisera are used
(14). Results similar to those shown in Table 1 were obtained
when the ELISA was run with 0.5 jig of parasite protein per
well rather than with equal numbers of parasites.
The IgM fraction of the stage-specific antisera was quan-
titatively and specifically less than the IgG fraction. There
was low-titer cross-reactivity between the three life stages
and their noncorresponding antisera (Table 1). The highest
specific IgM antibody response was directed against the
bradyzoite by its corresponding antiserum.
Further analysis of the stage-specific antigens was done by
Western blot (immunoblot). We have demonstrated previ-
ously that this technique is of adequate sensitivity to discern
strain-specific tachyzoite antigens of T. gondii (14). For
Western blot analysis, equal numbers of parasites were
analyzed by using the stage-specific mouse antitoxoplasma
sera. There were antigens unique to each of these T. gondii
stages (Fig. 2). The arrowheads in Fig. 2 indicate a number
of parasite antigens that appear to be unique to that stage or
perhaps present in quantitatively greater amounts than in the
other stages. In the normal brain tissue control, two low-
molecular-weight bands (<14,000) were recognized by the
antibradyzoite serum. One band (>97,000) was recognized
by the oocyst-sporozoite antiserum in sucrose gradient-
purified cat fecal material. There was no recognition of
normal human fibroblasts by the antitachyzoite serum. A
Western blot of the IgM fractions of the three mouse antisera
against their corresponding antigens failed to identify stage-
specific antigens that differed from those identified by the
IgG fraction (not shown).
A comparative Western blot analysis was performed to
determine if there are commonly shared antigens among
these three morphologic stages of T. gondii. This study was
done by evaluating equal numbers of parasites run in parallel
and then reacted with the three stage-specific mouse anti-
sera. Several parasite antigens appeared to be commonly
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FIG. 2. Comparison of antigens of the three major life-cycle
stages of T. gondii. Equal numbers (1.8 x 106 parasites per lane) of
toxoplasma bradyzoites (B), oocyst-sporozoites (O/S), and tachy-
zoites (T) were run on 12.5% polyacrylamide gel, transferred to
nitrocellulose paper, and reacted with corresponding mouse antisera
and assayed for IgG binding. Controls represent equal amounts of
protein from normal mouse brain purified by a dextran gradient for
bradyzoites (NB), cat fecal material purified by a sucrose gradient
(C), and uninfected human fibroblasts (HF). Arrowheads indicate
some of the stage-specific antigens. Molecular weight standards
(103) are indicated.
identified by the bradyzoite and tachyzoite mouse antisera
(Fig. 3). Most noteworthy is the cluster of tachyzoite and
bradyzoite antigens with Mrs of approximately 24,000 to
32,000, designated the P30 cluster (Fig. 3). There does not
appear to be recognition of antigens of this molecular weight
in the oocyst-sporozoite preparation. Curiously, the anti-
oocyst-sporozoite serum identified one of these antigens in
the tachyzoite preparation (as a doublet of approximate Mr
30,000) and in the bradyzoite preparation (as a single band of
approximate Mr 24,000) but not in its corresponding oocyst-
sporozoite preparation.
The best test for stage specificity is analysis with mono-
clonal antitoxoplasma antibodies. Monoclonal antibodies
have been raised against the tachyzoite and oocyst-sporo-
zoite stages (3, 4). The antitachyzoite monoclonal antibodies
used in this experiment were directed against the major
iodinatable surface membrane proteins, P30 and P22 (Mrs,
30,000 and 22,000, respectively). Both of these IgG mono-
clonal antibodies are able to immunoprecipitate their corre-
sponding antigens from radiolabeled, detergent-solubilized
tachyzoites. The anti-oocyst-sporozoite IgG monoclonal an-
tibodies have been previously described (3). To identify
stage-specific bradyzoite antigens, we developed a panel of
murine monoclonal antibodies against the bradyzoite stage.
The antibradyzoite monoclonal antibodies are of the IgM
isotype and do not immunoprecipitate or identify bradyzoite
antigens by Western blot analysis under denaturing condi-
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FIG. 3. Western blot analysis of commonly shared and cross-
reacting antigens of the three major life-cycle stages of T. gondii.
Equal numbers (1.8 x 106 parasites per lane) of toxoplasma were run
on 12.5% polyacrylamide gel, transferred to nitrocellulose paper,
reacted with appropriate mouse antitoxoplasma sera (antibradyzoite
[anti-B], anti-oocyst-sporozoite [anti-O/S], and antitachyzoite [anti-
T]) or control serum (pooled normal mouse sera [NMS]), and
assayed for IgG binding. Molecular weight standards (103) are
indicated.
of 250,000 against its corresponding stage (Table 2). This
was a -100-fold increase over titers of the noncorresponding
stages.
DISCUSSION
Our results show that there are T. gondii antigens unique
to the oocyst-sporozoite, tachyzoite, and bradyzoite stages
of this organism. These antigens can be identified by several
immunologic assays that use monoclonal and polyclonal
antibodies raised against each of these stages. The identifi-
cation of these unique antigens confirms that immunologic as
well as morphologic stage specificity of T. gondii exists.
The most conclusive data in support of stage specificity
concern the immunoreactivity demonstrated by monoclonal
TABLE 2. ELISA titers of stage-specific monoclonal antibodies





4B5 500 500 .50,000
3E9 50 50 .50,000
Antisporozoite
2E4 250,000 50 500
5A4 250,000 Negb Neg
Antitachyzoite
7B8 50 -50,000 500
7G1 Neg 5,000 50
a Parasites were used at a concentration of 104 per well.
b Neg, Negative.
antibodies raised against each of the three stages. These
antibodies were able to distinguish their corresponding
stages far better than they could distinguish noncorrespond-
ing stages. For example, monoclonal antibodies raised
against two major tachyzoite antigens (P30 and P22) were
100-fold more reactive with the tachyzoite stage than with
the oocyst-sporozoite and bradyzoite stages. Similarly, high-
titer (-50,000) anti-oocyst-sporozoite monoclonal antibod-
ies reacted poorly with bradyzoites and tachyzoites. The
development of an antibradyzoite monoclonal antibody li-
brary supports previous suggestions that antigenic speci-
ficity of this stage exists (8, 9). Because current epidemio-
logic evidence suggests that acute toxoplasmosis in patients
with acquired immune deficiency syndrome may represent
recrudescence of previous infection (7), the identification,
characterization, and purification of bradyzoite antigens may
in the future be of clinical importance in the serodiagnosis of
toxoplasmosis.
Further support for stage specificity of T. gondii antigens
was shown by ELISA and Western blot analysis. Despite
cross-reactivity among the various stages, the ELISA was
sufficiently sensitive to distinguish stage-specific antigens. In
general, the IgM titer was lower and less specific than the
IgG titer. The Western blot also distinguished stage-specific
antigens. Several of these antigens were not easily detected
by radioiodination, suggesting that they were not labeled by
the lodogen technique (thus being tyrosine deficient) or,
more likely, that some of the immunoreactive epitopes are
not proteins.
The identification of antigens shared among the three
stages of T. gondii is also important. Those antigens which
are recognized by their cross-reactivity with noncorrespond-
ing antisera may be of either membranous or cytoplasmic
origin. They may reflect a common biochemical thread that
runs through the rather complicated two-host life cycle of
this parasite. It is possible that some of the higher-molecular-
weight antigens are precursors of lower-molecular-weight
parasite membrane proteins.
Of particular interest is the P30 cluster of immunoreactive
proteins between Mrs 24,000 and 34,000. P30 is a major
tachyzoite membrane protein and is a component of the
vesicular network found within the parasitophorous vacuole
(12, 14). It is highly immunoreactive in Western blots with
the wild-type P or C strain but not with the RH strain.
Preliminary data from Western blot analysis by our labora-
tory suggest that the immunoreactive molecules of P30 may
be glycosylated (unpublished data). Our results show that
the antisera raised against the bradyzoite and tachyzoite
stages of T. gondii contain antibodies that react with proteins
in the P30 cluster. Further analysis of the bradyzoite and
tachyzoite proteins within the P30 cluster is under way; an
understanding of these proteins may be important in improv-
ing both serodiagnosis of and immunization against toxoplas-
mosis.
ACKNOWLEDGMENTS
This work was supported by Public Health Service grant AI-19613
from the National Institutes of Health and by the March of Dimes
Birth Defects Foundation.
I thank Patricia Ware for her technical assistance.
LITERATURE CITED
1. Frenkel, J. K., J. P. Dubey, and N. L. Miller. 1970. Toxoplasma
gondii in cats: fecal stages identified as coccidian oocysts.
Science 167:893-896.







672 KASPER INFECT. IMMUN.
1970. Coccidian-like nature of Toxoplasma gondii. Br. Med. J.
1:142-147.
3. Kasper, L. H., M. S. Bradley, and E. R. Pfefferkorn. 1984.
Identification of stage specific sporozoite antigens of Toxo-
plasma gondii by monoclonal antibodies. J. Immunol. 132:
443-449.3.
4. Kasper, L. H., J. H. Crabb, and E. R. Pfefferkorn. 1982.
Isolation and characterization of a monoclonal antibody resis-
tant mutant of Toxoplasma gondii. J. Immunol. 129:1694-1699.
5. Kasper, L. H., K. M. Currie, and M. S. Bradley. 1985. An
unexpected response to vaccination with a purified major mem-
brane tachyzoite antigen (P30) of T. gondii. J. Immunol. 134:
3426-3432.
6. Kasper, L. H., and P. L. Ware. 1985. Recognition and charac-
terization of stage-specific oocyst/sporozoite antigens of Toxo-
plasma gondii by human antisera. J. Clin. Invest. 75:1570-1577.
7. Luft, B. J., and J. S. Remington. 1988. Toxoplasmic encephali-
tis. J. Infect. Dis. 157:1-6.
8. Lunde, M. N., and L. Jacobs. 1983. Antigenic differences
between endozoites and cystozoites of Toxoplasma gondii. J.
Parasitol. 69:806-811.
9. Overdulve, J. P. 1970. The identity of Toxoplasma gondii. Proc.
K. Ned. Akad. Wet. Ser. C Biol. Med. Sci. 73:129-135.
10. Pfefferkorn, E. R., L. C. Pfefferkorn, and E. D. Colby. 1977.
Development of gametes and oocysts in cats fed cysts derived
from cloned trophozoites of Toxoplasma gondii. J. Parasitol.
63:158-165.
11. Sheffield, H. G., and M. L. Melton. 1970. Toxoplasma gondii:
the oocyst, sporozoite and infection of cultured cells. Science
167:892-896.
12. Sibley, L. D., J. D. Krahenbuhl, G. M. W. Adams, and E.
Weidner. 1986. Toxoplasma modifies macrophage phagosomes
by secretion of a vesicular network rich in surface proteins. J.
Cell Biol. 103:867-874.
13. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic
transfer of proteins from polyacrylamide gels to nitrocellulose
sheets: procedure and some applications. Proc. Natl. Acad. Sci.
USA 76:4350-4356.
14. Ware, P. L., and L. H. Kasper. 1987. Strain-specific antigens of
Toxoplasma gondii. Infect. Immun. 55:778-783.
